galectin-3 (B2C10) Antibody from Santa Cruz Biotechnology, Inc.

Yes, the galectin-3 (B2C10) antibody has been utilized in immunohistochemistry applications, as demonstrated in studies investigating its role in tumor microenvironments, such as the research on beta-D-glucose-reduced silver nanoparticles in triple-negative breast cancer, where it was used to assess galectin-3 expression levels in tissue samples (felixpin2024).

The galectin-3 antibody has been shown to work in flow cytometry assays, as indicated in studies that employed it to analyze cellular responses and interactions, including those related to lysosomal damage and endomembrane dynamics (corrotte2020).

The galectin-3 antibody is reactive with multiple species, including human, mouse, and rat, making it suitable for a variety of experimental models in cell biology and apoptosis research.

Yes, the galectin-3 antibody has been referenced in studies examining its role in autophagy and lysosomal function, particularly in the context of lysosomal damage and its signaling pathways, as seen in research that discusses the interaction of galectins with mTOR signaling in response to endomembrane damage (jia2018).